B cells, also known as B lymphocytes, are a type of white blood cell of the lymphocyte subtype. They function in the humoral immunity component of the adaptive immune system by secreting antibodies. Additionally, B cells present antigen (they are also classified as professional antigen-presenting cells (APCs)) and secrete cytokines.
B cells, unlike the other 2 classes of lymphocytes, T cells and natural killer cells, express B cell receptors (BCRs) on their cell membrane. BCRs allow the B cell to bind a specific antigen, against which it will initiate an antibody response.
B cells develop from hematopoietic stem cells (HSCs) that originate from bone marrow. HSCs first differentiate into multipotent progenitor (MPP) cells, then common lymphoid progenitor (CLP) cells. From here, their development into B cells occurs in several stages (shown in image to the right), each marked by various gene expression patterns and immunoglobulin H chain and L chain gene loci arrangements, the latter due to B cells undergoing V(D)J recombination as they develop.
B cells undergo two types of selection while developing in the bone marrow to ensure proper development. Positive selection occurs through antigen-independent signaling involving both the pre-BCR and the BCR. If these receptors do not bind to their ligand, B cells do not receive the proper signals and cease to develop. Negative selection occurs through the binding of self-antigen with the BCR; If the BCR can bind strongly to self-antigen, then the B cell undergoes one of four fates: clonal deletion, receptor editing, anergy, or ignorance (B cell ignores signal and continues development). This negative selection process is also known as central tolerance.
To complete development into mature b cells, immature B cells migrate from the bone marrow to the spleen as well as pass through two transitional stages: T1 and T2. Throughout their migration to the spleen and after spleen entry, they are considered T1 B cells. Within the spleen, T1 B cells transition to T2 B cells. T2 B cells differentiate into either follicular (FO) B cells or marginal zone (MZ) B cells depending on signals received through the BCR and other receptors. Once differentiated, they are now considered mature B cells, or naive B cells.
While immature and during the T1 phase, B cells express a BCR of class IgM, but BCR expression changes to the classes IgM and IgD after transition into the T2 phase and while mature up to activation.
B cell activation occurs in the secondary lymphoid organs (SLOs), such as the spleen and lymph nodes. After B cells mature in the spleen, they migrate through the blood to SLOs, which receive a constant supply of antigen through circulating lymph. At the SLO, B cell activation begins when the B cell binds to an antigen via its BCR. The antigen can either be free-floating or presented by APCs such as macrophages or dendritic cells (DCs), and include proteins, glycoproteins, polysaccharides, whole virus particles, and whole bacterial cells. Of the three B cell subsets, FO B cells preferentially undergo T cell-dependent activation while MZ B cells and B1 B cells preferentially undergo T cell-independent activation.
B cell activation is enhanced through the activity of CD21, a surface receptor in complex with surface proteins CD19 and CD81 (all three are collectively known as the B cell coreceptor complex). When a BCR binds an antigen tagged with a fragment of the C3 complement protein, CD21 binds the C3 fragment, co-ligates with the bound BCR, and signals are transduced through CD19 and CD81 to lower the activation threshold of the cell.
T cell-dependent activation
Antigens that activate B cells with T cell help are known as T cell-dependent (TD) antigens and include foreign proteins. They are named as such because they are unable to induce a humoral response in organisms that lack T cells. B cell response to these antigens takes multiple days, though antibodies generated have a higher affinity and are more functionally versatile than those generated from T cell-independent activation.
Once a BCR binds a TD antigen, the antigen is taken up into the B cell through receptor-mediated endocytosis, degraded, and presented to T cells as peptide pieces in complex with MHC-II molecules on the cell membrane. T helper (TH) cells, typically follicular T helper (TFH) cells, that were activated with the same antigen recognize and bind these MHC-II-peptide complexes through their T cell receptor (TCR). Following TCR-MHC-II-peptide binding, T cells express the surface protein CD40L as well as cytokines such as IL-4 and IL-21. CD40L serves as a necessary co-stimulatory factor for B cell activation by binding the B cell surface receptor CD40, which promotes B cell proliferation, immunoglobulin class switching, and somatic hypermutation as well as sustains T cell growth and differentiation. T cell-derived cytokines bound by B cell cytokine receptors also promote B cell proliferation, immunoglobulin class switching, and somatic hypermutation as well as guide differentiation. After B cells receive these signals, they are considered activated.
Now activated, B cells participate in a two-step differentiation process that yields both short-lived plasmablasts for immediate protection and long-lived plasma cells and memory B cells for persistent protection. The first step, known as the extrafollicular response, occurs outside of lymphoid follicles but still in the SLO. During this step activated B cells proliferate, may undergo immunoglobulin class switching, and differentiate into plasmablasts that produce early, weak antibodies mostly of class IgM. The second step consists of activated B cells entering a lymphoid follicle and forming a germinal center (GC), which is a specialized microenvironment where B cells undergo extensive proliferation, immunoglobulin class switching, and affinity maturation directed by somatic hypermutation. These processes are facilitated by TFH cells within the GC and generate both high-affinity memory B cells and long-lived plasma cells. Resultant plasma cells secrete large amounts of antibody and either stay within the SLO or, more preferentially, migrate to bone marrow.
T cell-independent activation
Antigens that activate B cells without T cell help are known as T cell-independent (TI) antigens and include foreign polysaccharides and unmethylated CpG DNA. They are named as such because they are able to induce a humoral response in organisms that lack T cells. B cell response to these antigens is rapid, though antibodies generated tend to have lower affinity and are less functionally versatile than those generated from T cell-dependent activation.
As with TD antigens, B cells activated by TI antigens need additional signals to complete activation, but instead of receiving them from T cells, they are provided either by recognition and binding of a common microbial constituent to toll-like receptors (TLRs) or by extensive crosslinking of BCRs to repeated epitopes on a bacterial cell. B cells activated by TI antigens go on to proliferate outside of lymphoid follicles but still in SLOs (GCs do not form), possibly undergo immunoglobulin class switching, and differentiate into short-lived plasmablasts that produce early, weak antibodies mostly of class IgM, but also some populations of long-lived plasma cells.
Memory B cell activation
Memory B cell activation begins with the detection and binding of their target antigen, which is shared by their parent B cell. Some memory B cells can be activated without T cell help, such as certain virus-specific memory B cells, but others need T cell help. Upon antigen binding, the memory B cell takes up the antigen through receptor-mediated endocytosis, degrades it, and presents it to T cells as peptide pieces in complex with MHC-II molecules on the cell membrane. Memory T helper (TH) cells, typically memory follicular T helper (TFH) cells, that were derived from T cells activated with the same antigen recognize and bind these MHC-II-peptide complexes through their TCR. Following TCR-MHC-II-peptide binding and the relay of other signals from the memory TFH cell, the memory B cell is activated and differentiates either into plasmablasts and plasma cells via an extrafollicular response or enter a germinal center reaction where they generate plasma cells and more memory B cells. It is unclear whether the memory B cells undergo further affinity maturation within these secondary GCs.
B cell types
- Plasmablast - A short-lived, proliferating antibody-secreting cell arising from B cell differentiation. Plasmablasts are generated early in an infection and their antibodies tend to have a weaker affinity towards their target antigen compared to plasma cell. Plasmablasts can result from T cell-independent activation of B cells or the extrafollicular response from T cell-dependent activation of B cells.
- Plasma cell - A long-lived, non-proliferating antibody-secreting cell arising from B cell differentiation. There is evidence that B cells first differentiate into a plasmablast-like cell, then differentiate into a plasma cell. Plasma cells are generated later in an infection and, compared to plasmablasts, have antibodies with a higher affinity towards their target antigen due to affinity maturation in the germinal center (GC) and produce more antibodies. Plasma cells typically result from the germinal center reaction from T cell-dependent activation of B cells, however they can also result from T cell-independent activation of B cells.
- Memory B cell - Dormant B cell arising from B cell differentiation. Their function is to circulate through the body and initiate a stronger, more rapid antibody response (known as the secondary antibody response) if they detect the antigen that had activated their parent B cell (memory B cells and their parent B cells share the same BCR, thus they detect the same antigen). Memory B cells can be generated from T cell-dependent activation through both the extrafollicular response and the germinal center reaction as well as from T cell-independent activation of B1 cells.
- Follicular (FO) B Cell (also known as a B-2 cell) - Most common type of B cell and, when not circulating through the blood, is found mainly in the lymphoid follicles of secondary lymphoid organs (SLOs). They are responsible for generating the majority of high-affinity antibodies during an infection.
- Marginal zone (MZ) B cell - Found mainly in the marginal zone of the spleen and serves as a first line of defense against blood-borne pathogens, as the marginal zone receives large amounts of blood from the general circulation. They can undergo both T cell-independent and T cell-dependent activation, but preferentially undergo T cell-independent activation.
- B-1 cell - Arises from a developmental pathway different from FO B cells and MZ B cells. In mice, they predominantly populate the peritoneal cavity and pleural cavity, generate natural antibodies (antibodies produced without infection), defend against mucosal pathogens, and primarily exhibit T cell-independent activation. A true homologue of mouse B-1 cells has not been discovered in humans, though various cell populations similar to B-1 cells have been described.
- B-2 cell - FO B cells and MZ B cells.
- Regulatory B (Breg) cell - An immunosuppressive B cell type that stops the expansion of pathogenic, pro-inflammatory lymphocytes through the secretion of IL-10, IL-35, and TGF-β. Also, it promotes the generation of regulatory T (Treg) cells by directly interacting with T cells to skew their differentiation towards Tregs. No common Breg cell identity has been described and many Breg cell subsets sharing regulatory functions have been found in both mice and humans. It is currently unknown if Breg cell subsets are developmentally linked and how exactly differentiation into a Breg cell occurs. There is evidence showing that nearly all B cell types can differentiate into a Breg cell through mechanisms involving inflammatory signals and BCR recognition.
Autoimmune disease can result from abnormal B cell recognition of self-antigens followed by the production of autoantibodies. Autoimmune diseases where disease activity is correlated with B cell activity include scleroderma, multiple sclerosis, systemic lupus erythematosus, type 1 diabetes, and rheumatoid arthritis.
Malignant transformation of B cells and their precursors can cause a host of cancers, including chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), hairy cell leukemia, follicular lymphoma, non-Hodgkin's lymphoma, and Hodgkin's lymphoma.
- Murphy, Kenneth (2012). Janeway's Immunobiology 8th Edition. New York, NY: Garland Science. ISBN 9780815342434.
- Cooper, Max D. (2015-01-01). "The early history of B cells". Nature Reviews Immunology 15 (3). doi:10.1038/nri3801.
- Kondo, Motonari (2010-11-01). "Lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors". Immunological Reviews 238 (1): 37–46. doi:10.1111/j.1600-065X.2010.00963.x. ISSN 1600-065X. PMC 2975965. PMID 20969583.
- Pelanda, Roberta; Torres, Raul M. (2012-04-01). "Central B-Cell Tolerance: Where Selection Begins". Cold Spring Harbor Perspectives in Biology 4 (4): a007146. doi:10.1101/cshperspect.a007146. ISSN 1943-0264. PMC 3312675. PMID 22378602.
- Martensson, Inga-Lill; Almqvist, Nina; Grimsholm, Ola; Bernardi, Angelina (2010). "The pre-B cell receptor checkpoint". FEBS Letters. doi:10.1016/j.febslet.2010.04.057.
- LeBien, Tucker W.; Tedder, Thomas F. (2008-09-01). "B lymphocytes: how they develop and function". Blood 112 (5): 1570–1580. doi:10.1182/blood-2008-02-078071. ISSN 0006-4971. PMC 2518873. PMID 18725575.
- Loder, By Florienne; Mutschler, Bettina; Ray, Robert J.; Paige, Christopher J.; Sideras, Paschalis; Torres, Raul; Lamers, Marinus C.; Carsetti, Rita (1999-07-01). "B Cell Development in the Spleen Takes Place in Discrete Steps and Is Determined by the Quality of B Cell Receptor–Derived Signals". The Journal of Experimental Medicine 190 (1): 75–90. doi:10.1084/jem.190.1.75. ISSN 0022-1007. PMID 10429672.
- Chung, James B.; Silverman, Michael; Monroe, John G. (2003-01-06). "Transitional B cells: step by step towards immune competence". Trends in Immunology 24 (6): 342–348. doi:10.1016/S1471-4906(03)00119-4. ISSN 1471-4906.
- Cerutti, Andrea; Cols, Montserrat; Puga, Irene (2013-01-01). "Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes". Nature Reviews Immunology 13 (2). doi:10.1038/nri3383. PMC 3652659. PMID 23348416.
- Harwood, Naomi E.; Batista, Facundo D. (2010-01-01). "Early Events in B Cell Activation". Annual Review of Immunology 28 (1): 185–210. doi:10.1146/annurev-immunol-030409-101216. PMID 20192804.
- Yuseff, Maria-Isabel; Pierobon, Paolo; Reversat, Anne; Lennon-Duménil, Ana-Maria (2013-01-01). "How B cells capture, process and present antigens: a crucial role for cell polarity". Nature Reviews Immunology 13 (7). doi:10.1038/nri3469.
- Nutt, Stephen L.; Hodgkin, Philip D.; Tarlinton, David M.; Corcoran, Lynn M. (2015-01-01). "The generation of antibody-secreting plasma cells". Nature Reviews Immunology 15 (3). doi:10.1038/nri3795.
- Asokan, Rengasamy; Banda, Nirmal K.; Szakonyi, Gerda; Chen, Xiaojiang S.; Holers, V. Michael (2013-01-01). "Human complement receptor 2 (CR2/CD21) as a receptor for DNA: Implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE)". Molecular Immunology 53 (1–2): 99–110. doi:10.1016/j.molimm.2012.07.002. PMC 3439536. PMID 22885687.
- Zabel, Mark D.; Weis, John H. (2001-03-01). "Cell-specific regulation of the CD21 gene". International Immunopharmacology. Unraveling Mechanisms and Discovering Novel Roles for Complement 1 (3): 483–493. doi:10.1016/S1567-5769(00)00046-1.
- Blum, Janice S.; Wearsch, Pamela A.; Cresswell, Peter (2013-01-01). "Pathways of Antigen Processing". Annual Review of Immunology 31 (1): 443–473. doi:10.1146/annurev-immunol-032712-095910. PMC 4026165. PMID 23298205.
- Crotty, Shane (2015-01-01). "A brief history of T cell help to B cells". Nature Reviews Immunology 15 (3). doi:10.1038/nri3803. PMC 4414089. PMID 25677493.
- MacLennan, Ian C. M.; Toellner, Kai-Michael; Cunningham, Adam F.; Serre, Karine; Sze, Daniel M.-Y.; Zúñiga, Elina; Cook, Matthew C.; Vinuesa, Carola G. (2003-08-01). "Extrafollicular antibody responses". Immunological Reviews 194: 8–18. ISSN 0105-2896. PMID 12846803.
- Shlomchik, Mark J.; Weisel, Florian (2012-05-01). "Germinal center selection and the development of memory B and plasma cells". Immunological Reviews 247 (1): 52–63. doi:10.1111/j.1600-065X.2012.01124.x. ISSN 1600-065X. PMID 22500831.
- Bortnick, Alexandra; Chernova, Irene; Quinn, William J.; Mugnier, Monica; Cancro, Michael P.; Allman, David (2012-06-01). "Long-Lived Bone Marrow Plasma Cells Are Induced Early in Response to T Cell-Independent or T Cell-Dependent Antigens". The Journal of Immunology 188 (11): 5389–5396. doi:10.4049/jimmunol.1102808. ISSN 0022-1767. PMC 4341991. PMID 22529295.
- McHeyzer-Williams, Michael; Okitsu, Shinji; Wang, Nathaniel; McHeyzer-Williams, Louise (2011-01-01). "Molecular programming of B cell memory". Nature Reviews Immunology. doi:10.1038/nri3128. PMC 3947622. PMID 22158414.
- Kurosaki, Tomohiro; Kometani, Kohei; Ise, Wataru (2015-01-01). "Memory B cells". Nature Reviews Immunology 15 (3). doi:10.1038/nri3802.
- Pillai, Shiv; Cariappa, Annaiah; Moran, Stewart T. (2005-01-01). "Marginal Zone B Cells". Annual Review of Immunology 23 (1): 161–196. doi:10.1146/annurev.immunol.23.021704.115728. PMID 15771569.
- Baumgarth, Nicole (2010-01-01). "The double life of a B-1 cell: self-reactivity selects for protective effector functions". Nature Reviews Immunology 11 (1). doi:10.1038/nri2901.
- Rosser, Elizabeth C.; Mauri, Claudia. "Regulatory B Cells: Origin, Phenotype, and Function". Immunity 42 (4): 607–612. doi:10.1016/j.immuni.2015.04.005. ISSN 1074-7613. PMID 25902480.
- Yanaba, Koichi; Bouaziz, Jean-David; Matsushita, Takashi; Magro, Cynthia M.; St.Clair, E. William; Tedder, Thomas F. (2008-06-01). "B-lymphocyte contributions to human autoimmune disease". Immunological Reviews 223 (1): 284–299. doi:10.1111/j.1600-065X.2008.00646.x. ISSN 1600-065X.
- III, Arthur L. Shaffer; Young, Ryan M.; Staudt, Louis M. (2012-01-01). "Pathogenesis of Human B Cell Lymphomas". Annual Review of Immunology 30 (1): 565–610. doi:10.1146/annurev-immunol-020711-075027. PMID 22224767.